Metronidazole clearance: a one-sample method and influencing factors

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Clinical Pharmacology
• Biopharmaceutics

Background:

• Accurate determination of drug clearance is crucial for effective therapeutic drug monitoring.
• Traditional methods for calculating drug clearance often require multiple blood samples, increasing patient burden and cost.
• Metronidazole is a widely used antibiotic with a well-established pharmacokinetic profile.

Purpose of the Study:

• To evaluate the feasibility of determining metronidazole clearance using a single plasma sample.
• To compare the accuracy and precision of one-sample clearance estimation with conventional multi-sample methods.
• To investigate the correlation between metronidazole clearance and various physiological and environmental factors.

Main Methods:

• Analysis of plasma and saliva concentrations of metronidazole from 36 subjects after 96 administrations.
• Estimation of volume of distribution using sex, age, body weight, and height.
• Correlation analysis between metronidazole clearance and factors like body weight, alcohol consumption, tobacco use, coffee/tea intake, age, and sex.
• Comparison of metronidazole clearance with antipyrine clearance in the same subjects.

Main Results:

• Metronidazole clearance can be accurately determined from a single plasma sample, dose, and estimated volume of distribution (r > 0.97).
• Plasma and saliva concentrations of metronidazole were found to be identical (r = 0.99).
• Body weight and alcohol consumption showed a positive correlation with metronidazole clearance, while age and alcohol consumption correlated with antipyrine clearance.

Conclusions:

• A single-sample method for metronidazole clearance determination is a valid and precise alternative to conventional methods.
• Environmental factors differentially influence the elimination rates of metronidazole and antipyrine, suggesting distinct metabolic pathways.
• This simplified approach can improve the efficiency of pharmacokinetic studies and clinical monitoring of metronidazole.